Saturday, 16 November 2019

Duloxetine Intermediates and Atorvastatin Intermediates Market Share | Growth and Size | Forecast To 2023

Market Highlights
The duloxetine and atorvastatin intermediates market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2023. 

The Global Duloxetine Intermediates and Atorvastatin Intermediates Market size is Estimated to be valued at USD 73,546.68 thousand by 2023 and is expected to register a CAGR of 4.04% during the forecast period. The duloxetine intermediates segment is expected to lead the market and register a substantial CAGR to reach USD 73,546.68 thousand by the end of 2023 owing to the rising rate of anxiety cases. Duloxetine intermediates are much in demand across the globe. The duloxetine intermediates segment is also projected to be the fastest-growing segment during the forecast period.

Americas dominated the market, accounting for the largest share of the market in 2017 and the regional market is projected to register a CAGR of 3.30% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Indian market is projected to exhibit the highest growth rate of 5.29% during the forecast period of 2018 to 2023.   


Duloxetine and Atorvastatin Intermediates Market Segment Analysis
The global duloxetine and atorvastatin intermediates market has been segmented on the basis of intermediate type, and region. On the basis of the intermediate type, the market has been divided into duloxetine intermediates and atorvastatin intermediates. The duloxetine intermediates segment held the majority market share in 2017. It is also expected to be the fastest growing, followed by the atorvastatin intermediates segment. Strong pipeline of drugs and increased penetration of generic drugs is driving the growth of the segment.

Duloxetine and Atorvastatin Intermediates Market Key Players
Market Research Future (MRFR) recognizes Jiangxi Aifeimu Technology Co., Ltd (China), Zhejiang Jiuzhou Pharmaceutical Co., Ltd (China), Jigs Chemicals (India), Manus Aktteva (India), Arch Pharmalabs (India), Afine Chemicals Ltd (China), Shodhana Laboratories (India), Fluorochem Ltd (UK), Chiral BioSciences Ltd (India) and Tokyo Chemical Industry Co., Ltd (Japan) as the key players in the global duloxetine intermediate & atorvastatin intermediates market.

Duloxetine and Atorvastatin Intermediates Market Regional Analysis
Geographically, the global duloxetine intermediate & atorvastatin intermediates market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, the Americas was the largest market for duloxetine intermediate & atorvastatin intermediates in 2017 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. Well-established healthcare infrastructure and the increase in adoption of duloxetine intermediate and atorvastatin intermediates for the treatment of various chronic disease and major mental disorders is a major driving factor for the growth of the duloxetine intermediate & atorvastatin intermediates market in Europe. Germany accounted for the largest market share of 25.8% in 2017, and the country-level market is projected to register a CAGR of 2.43% during the forecast period.


Key Findings of the Study:
  • The global duloxetine intermediate & atorvastatin intermediates market is projected to reach over USD 73,546.68 thousand by 2023 at 04% CAGR during the review period of 2018 to 2023.
  • Americas accounted for the largest market share with North America being the major contributor to the growth of the market.
  • The duloxetine intermediates segment is projected to register the highest CAGR of 4.25% during the forecast period owing to the rising rate of anxiety cases.
  • Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies.
Brows more healthcare related research reports:

Dermatology Diagnostic device Market Research Report- Global Forecast To 2022 https://www.marketresearchfuture.com/reports/dermatology-diagnostic-device-market-2154


About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
at No comments:

Cardiac Rehabilitation Devices Market Segmentation | Outlook and Application | Forecast To 2023

Market Highlights
The cardiac rehabilitation devices market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2023. The global cardiac rehabilitation devices market is estimated to be valued at USD 2,839.9 million by 2023 and is expected to register a CAGR of 6.2% during the forecast period. Cardiac rehabilitation is a medically managed program designed to improve cardiovascular health. The patient suffering from heart failure, heart attack, angioplasty, or heart surgery opts for CR programs.
The rising prevalence of cardiac diseases, adoption of an unhealthy lifestyle and increasing geriatric population are driving the growth of the global cardiac rehabilitation devices market.  However, the factor such as the high cost of cardiac rehabilitation devices and stringent government regulations hinders market growth.

The American accounts the largest market share in 2017. Followed by America, Europe holds the second position with 32.4% of market share in 2017. In Europe, West Europe holds the largest share. Whereas the Asia-Pacific is expected to register the fastest CAGR.

Market Research Future (MRFR) recognizes Brunswick Corporation(Rosemont, Illinois), Amer Sports (Helsinki, Finland), Core Health & Fitness, LLC(Calgary, Alberta), Honey well International Inc.( Morris Plains, New Jersey), OMRON Corporation (Japan), BioTelemetry, Inc(Malvern, PA), The ScottCare Corporation (US), LSI (US), Schiller(US), Scifit (Brunswick) (US) and ergoline GmbH (UK) as the key players in the global cardiac rehabilitation devices market.   


Segment Analysis
The global cardiac rehabilitation devices market is segmented into phases, patient, type, device and end users. On the basis of phase, the market is segmented into phase I, phase II, and phase III. The global cardiac rehabilitation devices market by patient is segmented into coronary artery bypass grafting, percutaneous coronary intervention, coronary artery disease, myocardial ischemia, and others. The coronary artery bypass grafting (CAGR) segment is expected to lead the market and register a substantial CAGR to reach USD 1,020.6 million by the end of 2023. The increasing geriatric population is expected to drive the market growth. On the basis of type, the market is segmented into outpatient and inpatient. Based on devices the market is segmented into ellipticals, blood pressure monitors and heart rate monitors. On the basis of end user, the market is segmented into rehab & specialty centers and hospitals & clinics.


Regional Analysis
Geographically, the global cardiac rehabilitation devices market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, the Americas was the largest market for cardiac rehabilitation devices in 2017 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The increasing prevalence of cardiovascular diseases and increasing obesity in Europe are driving the growth of the cardiac rehabilitation devices market in the region.

Key Findings of the Study:
  • The global cardiac rehabilitation devices market is projected to reach over USD 2,839.9 million by 2023 at 6.2% CAGR during the review period of 2018 to 2023.
  • Americas accounted for the largest market share with North America being the major contributor to the growth of the market.
  • By devices, the heart rate monitors segment is projected to register the highest CAGR of 6.51% during the forecast period owing to the rising number of heat patient.
  • Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies. Moreover, they are focusing on e-commerce for distribution.
Brows more healthcare related research reports:

Dermatology Diagnostic device Market Research Report- Global Forecast To 2022  https://www.marketresearchfuture.com/reports/dermatology-diagnostic-device-market-2154

Biopsy Devices Market Research Report              https://www.marketresearchfuture.com/reports/biopsy-devices-market-2250

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
at No comments:

Dermatology Diagnostic Devices Market Profile | Demand, Cost and Profit | Forecast To 2022

Market Overview:
The dermatology diagnostic device market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2022. The global Dermatology Diagnostic Device Market size to register a healthy CAGR during the forecast period (2016-2022). Dermatology diagnostic device market share is expected to witness significant growth due to evolving skin imaging technologies and increased incidences of skin cancer over the forecast period. The penetration of social media, television, and advertising have a tremendous impact on the consumer’s paying attention to aesthetics and physical appearance.

This has, in turn, raised interest in aesthetic surgeries and a variety of cosmetics. Dermatology devices have experienced rapid transformations in the past few years. Skin imaging technologies such as optical coherence tomography (OCT) q-space trajectory imaging (QTI) are extensively in used these days. Terahertz and polarized-light imaging techniques are gaining traction, thereby contributing to the market growth.


On the contrary, stringent regulatory requirements for medical devices, poor dermatology care, availability of low-cost substitutes, reimbursement issues, and competitive pricing of low-cost manufacturers are some of the major concerns likely to restrict the dermatology diagnostic device market in the foreseeable future.

Dermatology Diagnostic Device Market Competitive Dashboard:
The players operating in the global dermatology diagnostic device market include Alma Lasers, Ltd. (Israel), Valeant Pharmaceuticals (Canada), Lumenis, Ltd. (Israel), Cutera, Inc. (U.S.), Dino-Lite Europe/IDCP B.V., Cynosure, Inc. (U.S.), Michelson Diagnostics Ltd., (UK), Genentech, Inc., (US), Cutera, Inc. (US), and Galderma S.A., (Switzerland).

Global Dermatology Diagnostic Device Market Segmental Analysis
The dermatology diagnostic device market has been segmented on the basis of diagnostic devices, application, and end users.

By diagnostic device, the dermatology diagnostic device market is segmented into imaging devices, dermatoscopes, and microscopes. Of these, the dermatoscopes’ segment is predicted to gain prominence in the coming years.
By application, the dermatology diagnostic device market is segmented into skin cancer, lesion and others.
By end user, the market is segmented into research labs and centers, hospitals, institutions, and others. Of these, the hospitals’ segment is considered to gain prominence due to increasing demand and high availability for advanced dermatological equipment in hospital settings. Availability of several treatment options in hospitals is likely to propel the market growth in the segment.

Dermatology Diagnostic Device Market Regional Insights
Geographically, the dermatology diagnostic device market spans across Europe, America, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, North America is likely to dominate the market due to the surging prevalence of skin disorders like melanoma and psoriasis, soaring awareness regarding aesthetic procedures, and well-developed healthcare infrastructure. Rising awareness associated with aesthetic appeal, availability of advanced treatments, higher consumer disposable income, and increased adoption of cosmetic procedures are augmenting the market growth.


The Asia Pacific will gain prominence in the long run, with India and China exhibiting the fastest growth rates. The existence of a large patient population, improving living standards, and surging demand for quality medical care are some of the primary growth stimulants of the regional market. Also, increasing demand for quality medical care, rising awareness regarding healthcare, and increasing expenditure on healthcare will propel the market in the APAC.

Industry Updates
July 2019: Ra Medical Systems, Inc has recently declared that the company has launched Pharos, Optimized, which is considered the next generation of Pharos excimer lasers. It has been specifically designed to improve patient as well as physician experience with faster treatment of vitiligo, psoriasis, and atopic dermatitis.

Brows more healthcare related research reports:

Biopsy Devices Market - 

Cardiac Rehabilitation Devices Market -

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
at No comments:

Brazil Medical Devices Market Market SWOT Analysis, Key Players and Opportunities | Forecast To 2023

The Brazil medical devices market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2023. Brazil Medical Devices Market is expected grow at a CAGR of 9% over the assessment period (2017-2023).  Medical devices are devices that are utilized for medical purposes and benefit patients by aiding healthcare providers in diagnosing and treating patients as well as helping them to overcome a disease or sickness, thereby improving the quality of life. These devices help people in having healthier, longer and productive lives. There are abundant factors that is propelling the growth of the Brazil medical devices market.

These factors as per the report include advancements in processing power and connectivity of devices, need for early detection, cloud integration, demand for noninvasive therapies such as for cancer, growing awareness as well as spread of IT (information technology), availability of medical devices at nominal prices, transforming medical technology landscape, rising trade initiatives and government investments, increasing aging population, establishment of various manufacturing facilities in Brazil, creation of advanced ultrasound having assorted applications and developing healthcare infrastructure.


On the contrary, high sales tariffs, soaring price of imported medical devices, low penetration of medical devices, challenging regulatory environment in case of approval, sales and import of medical devices, political turmoil, poor regulatory framework and differential connectivity especially in inaccessible regions in Brazil are factors that are impeding the growth of the Brazil medical devices market.

Brazil Medical Devices Market Key Players
Leading players profiled in the Brazil medical devices market include St. Jude Medical Inc. (USA), Siemens AG (Germany), Koninklijke Philips Electronics NV. (Netherlands), Medtronic (USA), Johnson & Johnson (USA), Hitachi Medical Corporation (Japan), General Electric (USA), Fresenius Medical Care AG & Co. (Germany), Cardinal Health (USA), Boston Scientific Corporation (USA), Baxter International (USA), and others.

Brazil Medical Devices Market Segmentation
MRFR report offers a broad segmental analysis of the Brazil medical devices market on the basis of end users, therapeutic application and product type.

Based on end users, the Brazil medical devices market is segmented into hospitals, homes and ambulatory.
Based on product types, the Brazil medical devices market is segmented into stimulation devices, surgical devices, robotics, monitoring devices, molecular diagnostic devices, drug delivery devices, diagnostic devices, bioimplants, automation and others.


Based on therapeutic application, the Brazil medical devices market is segmented into respiratory applications, orthopedics application, ophthalmology, neurology application, nephrology and urology application, general surgery application, ear-nose-throat, diagnostic imaging application, dental application and cardiovascular application.

Brows more healthcare related research reports:

Dermatology Diagnostic device Market Research Report- Global Forecast To 2022 

Biopsy Devices Market Research Report    

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
at No comments:

Biopsy Devices Market Insights | Dynamics and Trends analysis | Forecast To 2022

The biopsy devices market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2022. Global Biopsy Devices Market size is expected to reach USD 2.4 Billion with expanding at a CAGR of 6% throughout the forecasted period (2016 – 2022). Biopsy devices are equipment used during biopsy procedures that are carried out for the diagnosis of cancer, kidney, lung diseases, and other several diseases. The global biopsy devices market is booming over the last couple of decades, mainly due to the increasing prevalence of kidney diseases and transplants. Besides, kidney diseases & disorders and other chronic conditions such as high blood pressure & diabetes are supporting the growth of the market, creating the demand for better diagnostic & treatments. Technological advancements and the proliferation of the Internet of Things (IoT) devices is fostering the growth of the market, bringing about smart and connected devices.

Additional factors propelling the biopsy devices market growth, include, the changing lifestyle due to the rapid urbanization and the improving economic conditions that are increasingly enabling access to improved healthcare. Furthermore, rising demand for new techniques for the diagnosis of chronic diseases, increasing numbers of biopsy procedures, and advancements in surgical procedures fuel the growth of the biopsy devices market.


Global Biopsy Devices Market Segments
The report is segmented into four market dynamics to widen the scope of understanding,
By Product Type
  • Biopsy Guidance System
  • Biopsy Guns
  • Biopsy Needles
  • Forceps
  • others
By Application
  • Skin biopsy
  • Surgical biopsy
  • Needle biopsy
  • Cancer Diagnosis
  • Bone marrow biopsy
  • others
By End-user 
  • Specialty Clinics
  • Hospitals
  • Diagnostic centers
  • Academic Research Institutes
Global Biopsy Devices Market Regional Analysis
North America leads with highest global biopsy devices market share, witnessing extensive adoption of technologically advanced medical devices. Moreover, factors such as increasing governmental support for R&D activities, and high health care expenditures foster regional market growth. Furthermore, the increasing prevalence of diabetes, kidney diseases, and renal failures boost the growth of the regional market. The biopsy devices market in North America is estimated to reach USD 2.4 BN by 2022.

The biopsy devices in the European region takes the second leading position. Factors such as the increasing emphasis on the development of advanced diagnostic devices and increasing funding and support from the government for R&D activities drive the regional market growth. Simultaneously, the rising numbers of specialty services offered by various healthcare providers foster the increase in the regional market.

The Asia Pacific biopsy devices market is rapidly emerging as a promising market globally. Rapidly developing healthcare technology alongside the rising numbers of urology centers provide impetus to the regional market growth. Growing incidences of diabetes and increasing numbers of kidney transplant procedures are boosting the market demand in the APAC region. The increasing demand for quality devices and improving economic conditions are some of the factors expected to fuel the growth of the biopsy devices market in the APAC region.


Major Players:
Key Players leading the global biopsy devices market include Precision Biopsy, LLC. (US), Cook Medical, Hologic, Inc., Scion Medical Technologies, LLC. (UK), Leica Biosystems, C. R. Bard, Inc., Argon Medical Devices, Inc., Creganna, Focal Therapeutics, Inc., and Integra LifeSciences Corporation, among others.

Brows more healthcare related research reports:

Dermatology Diagnostic device Market 

Cardiac Rehabilitation Devices Market 

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
at No comments:

Tuesday, 12 November 2019

Drug Discovery Informatics Market Profile | Dynamics and Key Players | Forecast To 2023

The Global Drug Discovery Informatics Market held a value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% over the forecast period. Drug discovery and development is an extremely complex process requiring the generation of very large amounts of information data and. As the pharmaceutical and biotechnology industry is on the rise, information technology is supporting the drug discovery process to improve research productivity and success rates. Patent expiry of blockbuster drugs, an over-reliance on high throughput discovery strategies, and ongoing industry consolidation through mergers and acquisitions (M&A) are fueling the demand for drug discovery informatics.

Few of the market growth factors include a worldwide rising focus on drug discovery, growing need to control drug discovery and development costs, rising research and development (R&D) expenditure, and increasing burden of chronic diseases. For instance, according to the Association of the British Pharmaceutical Industry (ABPI), the global pharmaceutical industry invested more than USD 1.36 trillion in R&D from 2007 to 2016, and it is projected to an annual investment of USD 181 billion by 2022. In contrast, high pricing and setup cost of informatics software is anticipated to limit the market growth during the forecast period.


Introduction of in-silico tools that facilitate computation with varied workflows that are in sync with the rate of modern medicinal chemistry is one of the key trends augmenting market growth. It involves different steps and procedures which depend on in-silico tools for reducing the complexity of the process. In-silico tools include modeling tools for the determination of 3D structures of ligand and protein-absorption, distribution, metabolism, excretion, and toxicity (ADMET) assessment-affinity estimation in docking and drug-ligand interaction for pharmacological profiling.

Drug Discovery Informatics Market Segmentation:
The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.
By product, the market has been segmented into discovery informatics and development informatics.
On the basis of mode, the market has been divided into in-house informatics and outsourced informatics. 
By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.
Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.


Drug Discovery Informatics Market Key Players:
Few of the foremost players in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

Brows More Healthcare Related Market Research Reports:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Healthcare Regulatory Affairs Outsourcing Market Trend Analysis | Supply and Segmentation | Forecast To 2023

The Global Healthcare Regulatory Affairs Outsourcing Market held a value of USD 3,120.4 million in 2017 and is projected to grow at a CAGR of 9.4% over the forecast period. The healthcare regulatory affairs outsourcing offers medical writing and publishing which plays an important role to develop high-quality documents for the clinical research process. The rising, increasing number of patent expirations and growing research and development activities are some factors that are likely to propel the market growth during the assessment period.
Additionally, the rising incidence of several chronic diseases such as cancer and other infectious diseases have encouraged biopharmaceutical companies to develop many new products. This rising development of products in clinical trials, the demand for clinical trial application and product registration services is increasing, thus driving the growth of this market.


For instance, the International Federation of Pharmaceutical Manufacturers & Associations stated that around 1,919 and 1,308 drugs are in development for cancer and neurology, respectively. Additionally, IFPMA stated that in 2014, there were 401 drugs in the pipeline for diabetes and 208 drugs in development for HIV/AIDS. Furthermore, IFPMA specified that their members have 119 ongoing R&D projects related to neglected tropical diseases.
On the other hand, the risk associated with data security and lack of standardization may hamper the market growth during the assessment period.

Currently, the global healthcare regulatory affairs outsourcing market is dominated by numerous prominent players. The key players operating in this market offer comprehensive knowledge in managing healthcare regulatory affairs. These companies mainly intend to help firms overcome challenges and accelerate clinical processes.
On a regional basis, the global healthcare regulatory affairs outsourcing market in the Americas is segmented into two major regions, i.e., North America and Latin America. The North American region is likely to hold the major share in the region is due to the increasing prevalence of chronic diseases. The rising prevalence of cancer and other chronic diseases demands the discovery of newer and effective drugs which is anticipated to fuel the market growth in this region.


For instance, according to the Centers for Disease Control and Prevention, in 2014, 9,421 new cases of tuberculosis were registered in the US. Moreover, according to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancer had been diagnosed in the US.

Brows More Healthcare Related Market Research Reports:
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com


at No comments:
Subscribe to: Posts (Atom)

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...